1. Maglio, PP, Sepulveda, MJ, Mabry, PL. Mainstreaming modeling and simulation to accelerate public health innovation. Am J Public Health. 2014;104(7):1181–6.
Google Scholar | Crossref | Medline | ISI2. O’Donnell, E, Atkinson, JA, Freebairn, L, Rychetnik, L. Participatory simulation modelling to inform public health policy and practice: rethinking the evidence hierarchies. J Public Health Policy. 2017;38(2):203–15.
Google Scholar | Medline3. Petitti, DB, Lin, JS, Owens, DK, Croswell, JM, Feuer, EJ. Collaborative modeling: experience of the U.S. Preventive Services Task Force. Am J Prev Med. 2018;54(1s1):S53–62.
Google Scholar | Crossref | Medline4. Habbema, JD, Wilt, TJ, Etzioni, R, et al. Models in the development of clinical practice guidelines. Ann Intern Med. 2014;161(11):812–8.
Google Scholar | Crossref | Medline5. Morgan, MG. Use (and abuse) of expert elicitation in support of decision making for public policy. Proc Natl Acad Sci U S A. 2014;111(20):7176–84.
Google Scholar | Crossref6. Vennix, JAM, Andersen, DF, Richardson, GP, Rohrbaugh, J. Model-building for group decision support: Issues and alternatives in knowledge elicitation. Eur J Oper Res. 1992;59(1):28–41.
Google Scholar | Crossref | ISI7. Refsgaard, JC, van der Sluijs, JP, Højberg, AL, Vanrolleghem, PA. Uncertainty in the environmental modelling process: a framework and guidance. Environ Model Softw. 2007;22(11):1543–56.
Google Scholar | Crossref8. Kopp, RE, DeConto, RM, Bader, DA, et al. Evolving understanding of Antarctic ice-sheet physics and ambiguity in probabilistic sea-level projections. Earth’s Future. 2017;5(12):1217–33.
Google Scholar | Crossref9. Iglesias, CP, Thompson, A, Rogowski, WH, Payne, K. Reporting guidelines for the use of expert judgement in model-based economic evaluations. Pharmacoeconomics. 2016;34(11):1161–72.
Google Scholar | Crossref | Medline10. Grigore, B, Peters, J, Hyde, C, Stein, K. Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment. Pharmacoeconomics. 2013;31(11):991–1003.
Google Scholar | Crossref | Medline11. Soares, MO, Sharples, L, Morton, A, Claxton, K, Bojke, L. Experiences of structured elicitation for model-based cost-effectiveness analyses. Value Health. 2018;21(6):715–23.
Google Scholar | Crossref12. Sankatsing, VDV, Juraniec, K, Grimm, SE, et al. Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis. Radiology. 2020;297(1):40–8.
Google Scholar | Crossref | Medline13. Veerman, JL, Van Beeck, EF, Barendregt, JJ, Mackenbach, JP. By how much would limiting TV food advertising reduce childhood obesity? Eur J Public Health. 2009;19(4):365–9.
Google Scholar | Crossref | Medline14. Apelberg, BJ, Feirman, SP, Salazar, E, et al. Potential public health effects of reducing nicotine levels in cigarettes in the United States. N Engl J Med. 2018;378(18):1725–33.
Google Scholar | Crossref | Medline15. Levy, DT, Mumford, EA, Cummings, KM, et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2035–42.
Google Scholar | Medline16. Levy, DT, Mumford, EA, Cummings, KM, et al. The potential impact of a low-nitrosamine smokeless tobacco product on cigarette smoking in the United States: estimates of a panel of experts. Addict Behav. 2006;31(7):1190–200.
Google Scholar | Crossref | Medline | ISI17. Peel, A, Jenks, M, Choudhury, M, et al. Use of expert judgement across NICE guidance-making programmes: a review of current processes and suitability of existing tools to support the use of expert elicitation. Appl Health Econ Health Policy. 2018;16(6):819–36.
Google Scholar | Crossref18. Bojke, L, Soares, MO, Claxton, K, et al. Reference case methods for expert elicitation in health care decision making. Med Decis Making. doi:0272989X211028236.
Google Scholar19. Cooke, RM. Experts in Uncertainty: Opinion and Subjective Probability in Science. New York: Oxford University Press; 1991.
Google Scholar20. Butler, AT, Thomas, MK, Pintar, KDM. Systematic review of expert elicitation methods as a tool for source attribution of enteric illness. Foodborne Pathog Dis. 2015;12(5):367–82.
Google Scholar | Crossref21. Gordon, TJ. The delphi method. Futures Res Methodol. 1994;2(3):1–30.
Google Scholar22. O’Hagan, AB, Caitlin, E, Daneshkhah, A, et al. Uncertain Judgements: Eliciting Experts’ Probabilities. New York: Wiley; 2006.
Google Scholar | Crossref23. Garthwaite, PH, Kadane, JB, O’Hagan, A. Statistical methods for eliciting probability distributions. J Am Stat Assoc. 2005;100(470):680–701.
Google Scholar | Crossref | ISI24. Hemming, V, Burgman, MA, Hanea, AM, McBride, MF, Wintle, BC. A practical guide to structured expert elicitation using the IDEA protocol. Methods Ecol Evol. 2018;9(1):169–80.
Google Scholar | Crossref25. Johnson, SR, Tomlinson, GA, Hawker, GA, Granton, JT, Feldman, BM. Methods to elicit beliefs for Bayesian priors: a systematic review. J Clin Epidemiol. 2010;63(4):355–69.
Google Scholar26. Speight, P, Palmer, S, Moles, D, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess. 2006;10(14):1–144, iii.
Google Scholar | Crossref | Medline27. Brown, BB. Delphi Process: A Methodology Used for the Elicitation of Opinions of Experts. Santa Monica (CA): RAND Corporation; 1968.
Google Scholar28. Gosling, JP . SHELF: the Sheffield Elicitation Framework. In: Dias, LC, Morton, A, Quigley, J, eds. Elicitation: The Science and Art of Structuring Judgement. Cham (UK): Springer International Publishing; 2018:61–93.
Google Scholar29. Grigore, B, Peters, J, Hyde, C, Stein, K. EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment. BMC Med Inform Decis Mak. 2017;17(1):131.
Google Scholar | Crossref | Medline30. Garber, AM, Phelps, CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16(1):1–31.
Google Scholar | Crossref | Medline | ISI31. Meltzer, D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ. 1997;16(1):33–64.
Google Scholar | Crossref | Medline | ISI32. Neumann, PJ, Sanders, GD, Russell, LB, Siegel, JE, Ganiats, TG. Cost-Effectiveness in Health and Medicine. Oxford (UK): Oxford University Press; 2016.
Google Scholar | Crossref33. Richardson, J. Cost utility analysis: what should be measured? Soc Sci Med. 1994;39(1):7–21.
Google Scholar | Crossref | Medline34. Page, MJ, McKenzie, JE, Bossuyt, PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Google Scholar | Crossref | Medline35. Kuntz, K, Sainfort, F, Butler, M, et al. Decision and simulation modeling alongside systematic reviews. In: Decision and Simulation Modeling in Systematic Reviews [online]. Rockville (MD): Agency for Healthcare Research and Quality; 2013.
Google Scholar36. Akpo, EIH, Jansen, IR, Maes, E, Simoens, S. Cost-utility analysis of lipegfilgrastim compared to pegfilgrastim for the prophylaxis of chemotherapy-induced neutropenia in patients with stage II-IV breast cancer. Front Pharmacol. 2017;8:614.
Google Scholar | Crossref | Medline37. Annemans, L, Bresse, X, Gobbo, C, Papageorgiou, M. Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium. J Med Econ. 2010;13(3):537–51.
Google Scholar | Crossref38. Banz, K , Eucomed CRT Steering Committee . Cardiac resynchronization therapy (CRT) in heart failure: a model to assess the economic value of this new medical technology. Value Health. 2005;8(2):128–39.
Google Scholar | Crossref | Medline39. Bojke, L, Claxton, K, Bravo-Vergel, Y, Sculpher, M, Palmer, S, Abrams, K. Eliciting distributions to populate decision analytic models. Value Health. 2010;13(5):557–64.
Google Scholar | Crossref | Medline40. Chiêm, JC, Macq, J, Speybroeck, N. Rule-based modeling of chronic disease epidemiology: elderly depression as an illustration. PLoS One. 2012;7(8):e41452.
Google Scholar | Crossref | Medline41. De Graeve, D, Smet, A, Mehnert, A, et al. Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis. Pharmacoeconomics. 2005;23(suppl 1):35–47.
Google Scholar | Crossref | Medline42. Dewilde, S, Verdian, L, Maclaine, GD. Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK. Curr Med Res Opin. 2009;25(8):2007–19.
Google Scholar | Crossref | Medline43. Dubinsky, MC, Johanson, JF, Seidman, EG, Ofman, JJ. Suspected inflammatory bowel disease: the clinical and economic impact of competing diagnostic strategies. Am J Gastroenterol. 2002;97(9):2333–42.
Google Scholar | Medline44. Duenas-Meza, E, Giraldo-Cadavid, LF, Karpf, E, et al. Cost-utility analysis of an integrated care program for children with asthma in a medium-income country. Pediatr Pulmonol. 2020;55(11):3110–8.
Google Scholar | Crossref | Medline45. Ekaette, E, Lee, RC, Cooke, DL, Iftody, S, Craighead, P. Probabilistic fault tree analysis of a radiation treatment system. Risk Anal. 2007;27(6):1395–410.
Google Scholar | Crossref | Medline | ISI46. Firoz, BF, Lee, SJ, Nghiem, P, Qureshi, AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol. 2006;142(2):175–82.
Google Scholar | Crossref | Medline47. Garay, OU, Palacios, A, Pichon-Riviere, A, et al. The cost-effectiveness of continuous versus intermittent renal replacement therapies in acute kidney injury: perspective of the social services for the elderly in Argentina. Value Health Reg Issues. 2019;20:142–8.
Google Scholar | Crossref | Medline48. Garthwaite, PH, Chilcott, JB, Jenkinson, DJ, Tappenden, P. Use of expert knowledge in evaluating costs and benefits of alternative service provisions: a case study. Int J Technol Assess Health Care. 2008;24(3):350–7.
Google Scholar | Crossref | Medline49. Gordon, LG, Hirst, NG, Mayne, GC, et al. Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. J Gastrointest Surg. 2012;16(8):1451–61.
Google Scholar | Crossref | Medline50. Grand, TS, Basarir, H, Jackson, LJ. The cost-effectiveness of oral contraceptives compared to ‘no hormonal treatment’ for endometriosis-related pain: an economic evaluation. PLoS One. 2019;14(1):e0210089.
Google Scholar | Crossref | Medline51. Grigore, B, Peters, J, Hyde, C, Stein, K. A comparison of two methods for expert elicitation in health technology assessments. BMC Med Res Methodol. 2016;16:85.
Google Scholar | Crossref | Medline52. Gyllensten, H, Hakkarainen, KM, Jönsson, AK, et al. Modelling drug-related morbidity in Sweden using an expert panel of pharmacists’. Int J Clin Pharm. 2012;34(4):538–46.
Google Scholar | Crossref | Medline53. Handels, RLH, Wimo, A, Dodel, R, et al. Cost-utility of using Alzheimer’s disease biomarkers in cerebrospinal fluid to predict progression from mild cognitive impairment to dementia. J Alzheimers Dis. 2017;60(4):1477–87.
Google Scholar | Crossref | Medline54. Hinde, S, McKenna, C, Whyte, S, et al. Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer. Br J Cancer. 2015;113(1):135–41.
Google Scholar | Crossref | Medline55. Hitimana, R, Lindholm, L, Mogren, I, et al. Incremental cost and health gains of the 2016 WHO antenatal care recommendations for Rwanda: results from expert elicitation. Health Res Policy Syst. 2019;17.